Related Experiment Video
Updated: May 30, 2026
08:20
Efficacy of Fu's Subcutaneous Needling on Sciatic Nerve Pain: Behavioral and Electrophysiological Changes in a Chronic Constriction Injury Rat Model
Published on: June 30, 2023
[Myofascial pain syndrome]
Félix Manuel Francisco Hernández1
1FEA de Reumatología, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Islas Canarias, España.
Reumatologia Clinica
|July 29, 2011
Summary
Myofascial pain syndrome involves regional muscle pain and trigger points. Treatment requires a multidimensional approach including exercises and, for resistant cases, trigger point injections.
Area of Science:
- Pain Medicine
- Neurology
- Musculoskeletal Disorders
Context:
- Myofascial pain syndrome (MPS) is a common condition characterized by regional pain originating from muscles.
- It involves taut bands of muscle with palpable trigger points (TPs) that cause local and referred pain.
- The exact pathophysiology remains unclear, but theories suggest neuromuscular junction dysfunction.
Purpose:
- To provide a comprehensive overview of myofascial pain syndrome.
- To discuss the diagnosis, causes, and physiopathology of MPS.
- To outline current and emerging treatment strategies for MPS.
Summary:
- MPS presents as regional muscle pain with specific trigger points.
- Potential causes include biomechanical factors, overuse, and repetitive microtrauma.
- Diagnosis relies on clinical history, physical examination, and TP assessment.
- Treatment is multidimensional, focusing on eliminating perpetuating factors, patient education, and home exercises.
- Physiotherapy, pharmacotherapy, and behavioral therapies are individualized.
- For refractory cases, trigger point infiltration with various agents is effective.
Impact:
- Highlights the importance of a multidimensional approach for effective MPS management.
- Emphasizes the role of patient education and home exercise programs.
- Underscores the efficacy of trigger point injections in treatment-resistant MPS cases.
Related Concept Videos
01:21Layers of Connective Tissue Proper
Fascia, a thin layer of fibrous connective tissue, is distributed throughout the body. It demarcates and forms a supportive covering over skeletal muscles, bones, blood vessels, and organs. There are three main types of facia— superficial fascia, deep fascia, and subserous fascia. These are all present at different depths in the body. Fascia reduces the friction and permits muscles, joints, and organs to easily slide against each other, facilitating movement of the body and preventing tearing...
01:31Skeletal Muscle Relaxants: Therapeutic Uses
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
01:21Skeletal Muscle Relaxants: Adverse Effects
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:28Disorders of the Skeletal Muscle
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...